T1	Outcomes 977 1032	interleukin-8 (IL-8) and tumor necrosis factor (TNF-α)
T2	Outcomes 1087 1198	the C-reactive protein (CRP), lactic acid dehydrogenase (LDH), white blood cell (WBC) count, amylase and lipase
T3	Outcomes 1394 1468	The plasma levels of IL-8, TNF-α, CRP, LDH, WBC count, amylase and lipase
T4	Outcomes 1604 1645	The plasma IL-8, TNF-α, CRP, lipase, LDH
T5	Outcomes 2092 2109	P<0.05 or P<0.01)
T6	Outcomes 2275 2287	there was no
T7	Outcomes 2377 2387	52 U/L vs.
T8	Outcomes 2388 2411	298 ± 71 U/L, P>0.05).
T9	Outcomes 2412 2415	The
T10	Outcomes 2621 2629	P<0.01).
T11	Outcomes 2630 2675	Compared with PN and EN groups, the incidence
T12	Outcomes 2679 2710	upper gastrointestinal bleeding
T13	Outcomes 2884 2915	13.4 ± 5.2 days, both P<0.01).
T14	Outcomes 2916 2940	There was no significant
T15	Outcomes 3077 3127	(bifidobacterium) resulted in significant lowering
T16	Outcomes 3135 3230	level of pro-inflammatory cytokines, earlier restoration of gastrointestinal function, decrease
T17	Outcomes 3234 3255	complications such as
